中文
Home
Protocols
Research fields
Biochemistry (1136)
Biophysics (86)
Cancer Biology (360)
Cell Biology (1658)
Developmental Biology (237)
Immunology (503)
Microbiology (984)
Molecular Biology (888)
Neuroscience (527)
Plant Science (903)
Stem Cell (195)
Systems Biology (254)
Bio-protocol journal
Special issues
Lab protocol hub
Request a Protocol
Submit
Submission procedure
Author guidelines
Submit a protocol
Editorial criteria
About
|
A high-quality database for basic life science protocols
Protocols
Research fields
Biochemistry (1136)
Biophysics (86)
Cancer Biology (360)
Cell Biology (1658)
Developmental Biology (237)
Immunology (503)
Microbiology (984)
Molecular Biology (888)
Neuroscience (527)
Plant Science (903)
Stem Cell (195)
Systems Biology (254)
Bio-protocol journal
Special issues
Lab protocol hub
Request a Protocol
Submit
Submission procedure
Author guidelines
Submit a protocol
Editorial criteria
About
This protocol was submitted by the author(s) of the original paper via Bio-protocol's "
Request a Protocol
" feature.
Original Research Paper
Astrocytes contribute to synapse elimination
via
type 2 inositol 1,4,5-trisphosphate receptor-dependent release of ATP
DOI: 10.7554/eLife.15043
eLIFE , Apr 12, 2016
Related protocols in the same article
+ Show more
Update your protocol
Immunostaining
Junhua Yang
Original Research Paper
Astrocytes contribute to synapse elimination
via
type 2 inositol 1,4,5-trisphosphate receptor-dependent release of ATP
eLIFE
, Apr 12, 2016
DOI:
10.7554/eLife.15043
Last updated date: Aug 24, 2020
View: 330
Download PDF
How to cite
Copy protocol link
Q&A
How to cite:
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
1. Yang, J. (2020). Immunostaining. Bio-protocol.
bio-protocol.org/prep463
.
2. Yang, J., Yang, H., Liu, Y., Li, X., Qin, L., Lou, H., Duan, S. and Wang, H.(2016). Astrocytes contribute to synapse elimination
via
type 2 inositol 1,4,5-trisphosphate receptor-dependent release of ATP. eLIFE . DOI:
10.7554/eLife.15043
Copyright:
Content may be subjected to copyright.
Q&A
Find out more
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.